Vergleich

TRIM11 Antibody

ArtNr OACA05892
Hersteller AVIVA Systems Biology
Menge 50 ug
Kategorie
Typ Antibody Polyclonal
Format Liquid
Applikationen IHC, ELISA
Specific against Human (Homo sapiens)
Host Rabbit
Isotype IgG
Konjugat/Tag Unconjugated
Citations [1]"TRIM E3 ligases interfere with early and late stages of the retroviral life cycle." Uchil P.D., Quinlan B.D., Chan W.T., Luna J.M., Mothes W. PLoS Pathog. 4:E16-E16(2008). [2]"TRIM11 binds to and destabilizes a key component of the activator-mediated cofactor complex (ARC105) through the ubiquitin-proteasome system." Ishikawa H., Tachikawa H., Miura Y., Takahashi N. FEBS Lett. 580:4784-4792(2006). [3]"The tripartite motif family identifies cell compartments." Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., Ballabio A. EMBO J. 20:2140-2151(2001).
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias BIA1;E3 ubiquitin-protein ligase TRIM11;Protein BIA1;RING finger protein 92;RING-type E3 ubiquitin transferase TRIM11;RNF92;tripartite motif-containing protein 11.
Versandbedingung Gekühlt
Lieferbar
Manufacturer - Type
Polyclonal Antibody
Manufacturer - Category
Root Catalog/Products/Polyclonal Antibodies, Root Catalog/Products/Primary Antibodies
Shipping Temperature
Wet Ice
Gene symbol
TRIM11
Gene Fullname
tripartite motif containing 11
Product format
Liquid
Reconstitution and storage
-20°C or -80°C
Description of target
E3 ubiquitin-protein ligase that promotes the degradation of insoluble ubiquitinated proteins, including insoluble PAX6, poly-Gln repeat expanded HTT and poly-Ala repeat expanded ARX. Mediates PAX6 ubiquitination leading to proteasomal degradation, thereby modulating cortical neurogenesis. May also inhibit PAX6 transcriptional activity, possibly in part by preventing the binding of PAX6 to its consensus sequences. May contribute to the regulation of the intracellular level of HN (humanin) or HN-containing proteins through the proteasomal degradation pathway. Mediates MED15 ubiquitination leading to proteasomal degradation. May contribute to the innate restriction of retroviruses. Upon overexpression, reduces HIV-1 and murine leukemia virus infectivity, by suppressing viral gene expression. Antiviral activity depends on a functional E3 ubiquitin-protein ligase domain. May regulate TRIM5 turnover via the proteasome pathway, thus counteracting the TRIM5-mediated cross-species restriction of retroviral infection at early stages of the retroviral life cycle.
Nucleotide accession_num
NM_145214
Protein accession_num
NP_660215
Protein name
E3 ubiquitin-protein ligase TRIM11
Clonality
Polyclonal
Purification
Protein G Purified
Immunogen
Recombinant Human E3 ubiquitin-protein ligase TRIM11 protein (267-468AA)
Formulation
50% Glycerol, 0.01M PBS, PH 7.4

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 50 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen